Robert C. Doebele, MD, PhD (IMAGE) University of Colorado Anschutz Medical Campus Caption Robert C. Doebele, MD, PhD, and colleagues update the effectiveness of entrectinib against ROS1+ and NTRK+ cancers. Credit University of Colorado Cancer Center Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.